Latest Breaking News On - பயோனிக்ஸ் லிமிடெட் - Page 1 : comparemela.com
Insights on the Prosthetic Arm Global Market to 2026 - Increasing Cases of Amputations are Expected to Fuel the Market
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Global Neurorehabilitation Devices Market 2021:Size,Share,Trends,Competitive Analysis,Forecast To 20
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
This is the latest speculative ASX tech buy from Citigroup
Brendon Lau | January 6, 2021 10:46am |
More on: Image source: Getty Images
If you are on the hunt for the next shooting star in the small-cap tech sector, Citigroup may have just the trick for you.
Appetite for such stocks is strong after
Brainchip Holdings Ltd(ASX: BRN) share price,
Pointerra Ltd(ASX:3DP) share price and
Tesserent Ltd(ASX: TNT) shot out the lights in 2020.
These stocks gained more than 700% over the past 12 months when the
Big rewards and risks for this ASX small cap tech stock
If you want big rewards, you have to be prepared to stomach big risks. On that front, Citigroup reckons the
Citi have retained their
buy rating and $24.00 price target on this investment platform provider’s shares. The broker points out that the company has signed an agreement with
IOOF Holdings Limited (ASX: IFL). While it sees some risks from the deal, overall it views it as a positive. In addition to this, the broker believes HUB24 is well-placed to benefit from the ongoing structural shift in wealth management. The HUB24 share price is changing hands for $20.82 on Thursday.
A note out of
Morgan Stanley reveals that its analysts have retained their
overweight rating and $3.15 price target on this private health insurer’s shares. This follows the decision of the Federal Government to authorise a 3.25% increase in its premiums in 2021. It believes this is a positive for Medibank, though acknowledges that increasing premiums could lead to affordability issues for consumers. The Medibank share price is changing hands for $3.01 on Thursday afternoon.